tiprankstipranks
Trending News
More News >
BioView Ltd. (IL:BIOV)
:BIOV
Israel Market

Bio View (BIOV) Financial Statements

Compare
0 Followers

Bio View Financial Overview

Bio View's market cap is currently 26.98M. The company's EPS TTM is -0.024; its P/E ratio is 42.42; Bio View is scheduled to report earnings on ―, and the estimated EPS forecast is ―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue 25.66M 34.77M 29.14M 30.51M 25.96M
Gross Profit 15.56M 21.38M 16.67M 17.59M 15.78M
Operating Income -2.88M 766.00K 1.15M 2.95M 1.20M
EBITDA -943.00K 2.93M 2.61M 4.03M 2.43M
Net Income -3.15M 383.00K 587.00K 2.18M 884.00K
Balance Sheet
Cash & Short-Term Investments 10.94M 17.11M 19.44M 19.22M 17.24M
Total Assets 33.62M 41.95M 41.93M 40.02M 33.89M
Total Debt 1.98M 3.51M 4.06M 4.61M 1.46M
Net Debt -6.24M -12.18M -15.38M -14.62M -15.78M
Total Liabilities 10.68M 14.65M 13.65M 12.86M 8.82M
Stockholders' Equity 22.95M 27.30M 28.28M 27.16M 25.07M
Cash Flow
Free Cash Flow -3.14M -121.00K 511.00K 2.59M 498.00K
Operating Cash Flow -3.11M 153.00K 968.00K 3.25M 802.00K
Investing Cash Flow -1.54M -1.67M -567.00K -740.00K -313.00K
Financing Cash Flow -2.95M -2.68M -1.61M -268.00K -1.60M
Currency in ILS

Bio View Earnings and Revenue History

Bio View Debt to Assets

Bio View Cash Flow

Bio View Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis